Clinical Trials
Search Form
| Disease Site | Trial Sort ascending | Trial Description | Trial Status | Lead Cooperative Group |
|---|---|---|---|---|
| Symptom Benefit | ENGOT-OV22/ NOGGO S8 / Expression IV |
Ovarian cancer patients’ expectations in respect of maintenance therapy |
Completed | NOGGO |
| Symptom Benefit | ENGOT-EN16/ NOGGO S22/ Expression XI |
IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life |
Recruiting | NOGGO |
| Symptom Benefit | ENGOT -gyn4/ NOGGO S20/ Expression IX |
Long-term survival with gynecological cancer |
Recruiting | NOGGO |
| Symptom Benefit/Ovarian | SYMPTOM BENEFIT |
Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer? |
Completed | ANZGOG |
| Translational Research | ENGOT-OV47/ NOGGO TR2/ HELP-ER |
Prospective Study of HE4 serum Level in Patients with First Platinum Sensitive Ovarian Cancer Relapse |
Recruiting | NOGGO |
| Uterine Leiomyosarcoma | GOG0277 |
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observtion in Treating Patients with High Risk Uterine Leiomyosarcoma Previously removed by Surgery |
Completed | GOG-F |
| Uterine Sarcoma | EORTC 62113-55115 |
A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment |
Recruiting | EORTC-GCG |
| Vulvar | GROINSS-V3 |
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII) |
Recruiting | DGOG |
| Vulvar | GOG0279 |
Radiation Therapy, Gemcitabine Hydrochloride and Cisplatin in Treating Patients with Locally Advanced Squamous Cell Carcinoma of the Vulva |
Recruiting | GOG-F |